Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q4 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −3,500−100.0% | Sold out | Holders |
| Q2 2024 | 3,500 | $1.64M | 0.1% | −2,269−39.3% | Reduced | Holders |
| Q1 2024 | 5,769 | $2.41M | 0.2% | −71,034−92.5% | Reduced | Holders |
| Q4 2023 | 76,803 | $31.3M | 1.6% | +71,624+1,383.0% | Added | Holders |
| Q3 2023 | 5,179 | $1.80M | 0.3% | +4,060+362.8% | Added | Holders |
| Q2 2023 | 1,119 | $393.8K | 0.1% | +1,119 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −3,826−100.0% | Sold out | Holders |
| Q4 2022 | 3,826 | $1.10M | 0.1% | −1,232−24.4% | Reduced | Holders |
| Q3 2022 | 5,058 | $1.46M | 0.3% | +3,943+353.6% | Added | Holders |
| Q2 2022 | 1,115 | $314.0K | <0.1% | +1,115 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −2,031−100.0% | Sold out | Holders |
| Q4 2021 | 2,031 | $446.0K | 0.1% | −2,396−54.1% | Reduced | Holders |
| Q3 2021 | 4,427 | $803.0K | 0.1% | +4,427 | New | Holders |